Medicine and Dentistry
Pacritinib
100%
Janus Kinase 2
57%
Phosphotransferase
42%
Receptor
28%
Colony Stimulating Factor 1
28%
Bone Marrow Suppression
28%
Interleukin 1 Receptor Associated Kinase 1
28%
Protein Tyrosine Kinase
14%
Diseases
14%
Solid Malignant Neoplasm
14%
Serositis
14%
Combination Therapy
14%
Acute Myeloid Leukemia
14%
Cytokine
14%
STAT3 Protein
14%
Development
14%
Myelodysplastic Syndrome
14%
Myelofibrosis
14%
Protein Kinase Fer
14%
Janus Kinase 2 Inhibitor
14%
Chronic Myelomonocytic Leukemia
14%
Analysis
14%
Pharmacology, Toxicology and Pharmaceutical Science
Pacritinib
100%
Janus Kinase 2
57%
Phosphotransferase
42%
Receptor
28%
Bone Marrow Suppression
28%
Colony Stimulating Factor 1
28%
Interleukin 1 Receptor Associated Kinase 1
28%
Diseases
14%
Solid Malignant Neoplasm
14%
Inflammation
14%
Cytokine
14%
Myelodysplastic Syndrome
14%
Acute Myeloid Leukemia
14%
STAT3 Protein
14%
Myelofibrosis
14%
Janus Kinase 2 Inhibitor
14%
Chronic Myelomonocytic Leukemia
14%
Protein Kinase Fer
14%
Biochemistry, Genetics and Molecular Biology
Janus Kinase 2
71%
Kinase
42%
Colony Stimulating Factor 1 Receptor
28%
Interleukin-1 Receptor-Associated Kinase
28%
Kinome
28%
Receptor Tyrosine Kinase
14%
IC50
14%
Solid
14%
Cytokines
14%
Development
14%
STAT3
14%
Myeloid
14%
Dose
14%
Agricultural and Biological Sciences
Janus Kinase 2
71%
Colony Stimulating Factor 1 Receptor
28%
Kinome
28%
Receptor Tyrosine Kinase
14%
Myeloid
14%
Stems
14%